Beckman Coulter, Inc. develops, manufactures, and markets diagnostic systems that automate complex biomedical testing. The company’s research and discovery products and services include capillary electrophoresis, centrifugation, centrifugation (analytical), chemiluminescence, electrochemistry, flow cytometry, genetic analysis, genomic services, immunoassay, liquid handlers, next generation library construction, nucleic acid sample preparation, particle characterization, research automation, single cell PCR, and spectrophotometers for use in cellular solutions, drug discovery and development, genetic analysis, genomic services, protein analysis, and small molecule analysis. Its clinical produ...
250 South Kraemer Boulevard
Brea, CA 92821
Founded in 1935
Beckman Coulter to Shut Galway Facility with the Loss of 140 Jobs
Oct 2 14
Beckman Coulter announced to shut its Galway facility with the loss of 140 jobs. The company has said up to 80 staff will be offered redeployment at its facility in Co Clare.
Beckman Coulter Receives Contract for Z1 Dual Threshold Particle Counter Maintenance from University of Mary Washington
May 23 14
University of Mary Washington has awarded a contract (No. 14-59) for Z1 dual threshold particle counter maintenance agreement (93863) to Beckman Coulter on May 22, 2014.
Beckman Coulter Diagnostics Announces Availability of New Prostate Cancer Blood Test
Apr 25 14
Beckman Coulter Diagnostics has announced the availability of the Prostate Health Index, or phi, a non-invasive blood test that is reportedly three times more specific in detecting prostate cancer than PSA, or prostate-specific antigen. The new test's accuracy decreases the need for many men who test positive for elevated PSA levels to undergo a biopsy in order to achieve a reliable diagnosis. Results of a multi-center clinical study found a 31% reduction in unnecessary biopsies due to false-positives as a result of using the phi test. The phi test is available to physicians nationwide through Innovative Diagnostics Laboratory (IDL), a national clinical reference laboratory specializing in personalized blood-based testing to find, understand and treat cancer.